Pauline Kenny - Net Worth and Insider Trading
Pauline Kenny Net Worth
The estimated net worth of Pauline Kenny is at least $12,565 dollars as of 2024-11-05. Pauline Kenny is the General Counsel & Secretary of Kineta Inc and owns about 18,448 shares of Kineta Inc (KANT) stock worth over $12,565. Details can be seen in Pauline Kenny's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pauline Kenny has not made any transactions after 2023-09-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pauline Kenny
Pauline Kenny Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pauline Kenny owns 2 companies in total, including Yumanity Therapeutics Inc (YMTX) , and Kineta Inc (KANT) .
Click here to see the complete history of Pauline Kenny’s form 4 insider trades.
Insider Ownership Summary of Pauline Kenny
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| YMTX | Yumanity Therapeutics Inc | 2022-12-16 | General Counsel |
| KANT | Kineta Inc | 2023-09-20 | General Counsel |
Pauline Kenny Latest Holdings Summary
Pauline Kenny currently owns a total of 1 stock. Pauline Kenny owns 18,448 shares of Kineta Inc (KANT) as of September 20, 2023, with a value of $12,565.
Latest Holdings of Pauline Kenny
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KANT | Kineta Inc | 2023-09-20 | 18,448 | 0.68 | 12,565 |
Holding Weightings of Pauline Kenny
Pauline Kenny Form 4 Trading Tracker
According to the SEC Form 4 filings, Pauline Kenny has made a total of 2 transactions in Kineta Inc (KANT) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Kineta Inc is the acquisition of 1,500 shares on September 20, 2023, which cost Pauline Kenny around $3,870.
Insider Trading History of Pauline Kenny
- 1
Pauline Kenny Trading Performance
GuruFocus tracks the stock performance after each of Pauline Kenny's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pauline Kenny is 79.64%. GuruFocus also compares Pauline Kenny's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pauline Kenny within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pauline Kenny's insider trading performs compared to the benchmark.
Performance of Pauline Kenny
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 65.2 | | | | | |
| Relative Return to S&P 500(%) | 69.24 | | | | | |
Pauline Kenny Ownership Network
Ownership Network List of Pauline Kenny
Ownership Network Relation of Pauline Kenny
Pauline Kenny Owned Company Details
What does Yumanity Therapeutics Inc do?
Who are the key executives at Yumanity Therapeutics Inc?
Pauline Kenny is the General Counsel of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , Chief Scientific Officer Thierry Guillaudeux , and Chief Financial Officer Keith Baker .
Yumanity Therapeutics Inc (YMTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Yumanity Therapeutics Inc Insider Transactions
Pauline Kenny Mailing Address
Above is the net worth, insider trading, and ownership report for Pauline Kenny. You might contact Pauline Kenny via mailing address: C/o Kineta, Inc., 219 Terry Ave. N., Suite 300, Seattle Wa 98109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
